ARCHIVES

Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

Litton Loses To PRI On Largest Frederick Contract, Competing Against Hopkins For Science Program

August 27, 1982

Centers Network Release “Version 1.0” Of Clinical Guidelines for Eight Cancers

March 15, 1996

NCI Advisory Group, Other Cancer Meetings

February 28, 1986

In Brief: Basic Research Chief At Frederick Will Be A Nominal Litton Employee To Avoid NCI Staff, Salary Ceilings

March 1, 1974

Without Advisor’s Input, Healy Approves Protocol For Gene Therapy

January 15, 1993

In Brief: Richard Fisher Named Fox Chase President and CEO

August 2, 2013